L26/P-651 Clinical characteristics and whole exome sequencing results of recurrent oocyte maturation defects and or early embryonic developmental arrest
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.981 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von B. Kara und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Can clinical characteristics of patients and whole exome sequencing(WES) be informative in diagnosis of patients with recurrent oocyte maturation defects(OMD) and preimplantation embryo developmental arrest(PEDA)? Summary answer High prevalence of pathogenic variants was detected in patients with OMD and/or PEDA particularly in young cases with unexplained infertility and repeated unsuccessful ART cycles. What is known already Oocyte and early embryo competence defects have recently been recognized as a distinct cause of female infertility. In ART practice, the most challenging female infertility cases are those in which the same serious problems recur in repeated ART cycles: low numbers of or no mature oocytes (OMD) and/or low rates of or no embryonic development (PEDA). Recurrent OMD and or PEDA leads to repeated ART failure, particularly in young women without age related factors. The etiology remains largely undefined, however, with the advancements in genetics and widespread availability of WES, more genes involved in infertility are being identified each year. Study design, size, duration This retrospective cohort study comprised 108 women with recurrent OMD and/or PEDA analyzed with WES between 2018 and 2025 at Istanbul Memorial Hospital and Create Fertility Centre (Toronto). Patients were selected using standardized, statistically derived endophenotype criteria developed from a reference dataset of 14,551 IVF cycles, enabling precise classification of extreme phenotypes of OMD or PEDA. Participants/materials, setting, methods WES was performed in female partners and variants were classified according to ACMG criteria. A total of 108 cases with OMD and or PEDA who underwent WES were evaluated. Demographic characteristics, cycle level outcomes, and pregnancy outcomes were recorded. Data are mean ± SD or median (min to max); categorical variables are numerator/denominator (percentage%). Main results and the role of chance We identified 108 women (mean age 33.47 ± 4.37 years) with long standing unexplained infertility (median 6.0 [1.0 to 21.0] years), preserved ovarian reserve, and recurrent OMD and or PEDA across multiple ART cycles (median 4.0 [1 to 16]). Parental consanguinity was present in 37/108 patients (34.3%). Fifty-seven of 108 patients (52.8%) carried pathogenic, likely pathogenic, or uncertain-significance variants in genes implicated in oocyte maturation or embryo development. Miscarriage rate was high and similar between variant positive and negative patients (13/18 [72.2%] vs 16/23 [69.6%], p = 0.852). Live birth rate per embryo transfer cycle was extremely low and similar between groups (5/101 [5.0%] vs 7/100 [7.0%], p = 0.539). In subgroup analysis, Group 1 represented a genetically high-risk genotype group, defined as homozygous or compound heterozygous variants in autosomal recessive (AR) genes or heterozygous variants in autosomal dominant (AD) genes (31 patients, 110 cycles), whereas Group 2 included patients with heterozygous variants in AR genes only (26 patients, 112 cycles). Cycles reaching embryo transfer, pregnancy test results, and pregnancy outcomes were similar between these subgroups (p > 0.05 for all). Limitations, reasons for caution Functional studies are needed to confirm the newly discovered rare variants in this study and to assess the functional effect of the pathogenic variants and family studies to investigate the segregation of variants in the family. Wider implications of the findings An underlying genetic cause of these rare and unexplained infertility phenotypes should be considered, particularly in young cases with long-term unexplained infertility and repeated unsuccessful ART cycles. The identification of variants associated with OMD and PEDA has direct implications for diagnosis, counseling, and the rational avoidance of futile ART attempts. Trial registration number No
Zitieren
APA
Kara, B., Cetinkaya, M., Madjunkova, S., Aktoz, F., & Kahraman, S. (2026). L26/P-651 Clinical characteristics and whole exome sequencing results of recurrent oocyte maturation defects and or early embryonic developmental arrest. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.981
Vancouver
Kara B, Cetinkaya M, Madjunkova S, Aktoz F, Kahraman S. L26/P-651 Clinical characteristics and whole exome sequencing results of recurrent oocyte maturation defects and or early embryonic developmental arrest. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.981
BibTeX
@article{Kara2026,
author = {Kara, B. and Cetinkaya, M. and Madjunkova, S. and Aktoz, F. and Kahraman, S.},
title = {L26/P-651 Clinical characteristics and whole exome sequencing results of recurrent oocyte maturation defects and or early embryonic developmental arrest},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.981}
}
EUVIMED